http://www.mmm-online.com/payers/topic/17978/ Articles tagged with Payers from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no AstaZeneca avoids a Lipitor moment, FDA approves Novartis med for Cushing's, and Teva ventures into South Korea. Plus: a closer look at health exchanges http://www.mmm-online.com/company-news-astrazeneca-novartis-teva/article/272860/ Mon, 17 Dec 2012 17:17:53 GMT AstaZeneca avoids a Lipitor moment, FDA approves Novartis med for Cushing's, and Teva ventures into South Korea. Plus: a closer look at health exchanges MMM Price increases and belt-tightening helped prop up Eli Lilly's third quarter, but loss of formulary positioning on two key products hurt sales. http://www.mmm-online.com/lilly-sales-dip-11-as-diabetes-drugs-feel-payer-pressure/article/265184/ Wed, 24 Oct 2012 16:23:21 GMT Price increases and belt-tightening helped prop up Eli Lilly's third quarter, but loss of formulary positioning on two key products hurt sales. MMM IMS has added claims data to its real-world evidence (RWE) platform, but can it satisfy industry's demand for RWE as well as a payer can? http://www.mmm-online.com/ims-pitches-expanded-real-world-evidence-platform-to-pharma/article/259001/ Fri, 14 Sep 2012 13:52:58 GMT IMS has added claims data to its real-world evidence (RWE) platform, but can it satisfy industry's demand for RWE as well as a payer can? MMM Double Helix, a healthcare consultancy that operates across three continents, was bought by Interpublic Group's McCann Health, the network said Monday. http://www.mmm-online.com/mccann-health-buys-global-market-research-consultancy/article/247285/ Mon, 25 Jun 2012 18:01:29 GMT Double Helix, a healthcare consultancy that operates across three continents, was bought by Interpublic Group's McCann Health, the network said Monday. MMM Pharma needs to step up its sales pitch, looking beyond a drug's top attributes, to convince payers that their drugs are worth the cost. http://www.mmm-online.com/pharmas-are-from-mars-payers-are-from-venus/article/241644/ Thu, 17 May 2012 19:17:06 GMT Pharma needs to step up its sales pitch, looking beyond a drug's top attributes, to convince payers that their drugs are worth the cost. MMM